All In Biotech

Drug Trial Radar · NCT03963232

A Study of Galcanezumab (LY2951742) in Participants With Episodic Migraine

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Galcanezumab in Patients With Episodic Migraine-the Persist Study

Last checked: Nov 20, 2026Latest source record: Mar 28, 2023 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 520 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

520

Actual

Start

Jul 30, 2019

Primary completion

Jul 27, 2021

Study completion Mar 11, 2022

Sponsor

Lead sponsor
Eli Lilly and CompanyEli Lilly (LLY)
Sponsor type
Industry
First posted
May 24, 2019

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 65 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The reason for this study is to see if the drug galcanezumab is safe and effective in participants with episodic migraine. The study will last about 53 weeks and may include up to 12 visits.

Conditions

  • Episodic Migraine

Interventions

  • GalcanezumabDrug

    Administered SC

  • PlaceboDrug

    Administered SC

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Overall Mean Change From Baseline in the Number of Monthly Migraine Headache Days (MHDs) During the Double-blind Treatment Phase.Time frame: Baseline, 3 Months

Locations

40 sites in 3 countries. Site status is shown where the registry gives one.

  • Xuanwu Hospital-Capital Medical University

    Beijing, Beijing Municipality, China

  • Chinese PLA General Hospital

    Beijing, Beijing Municipality, China

  • The First Affiliated Hospital Chongqing Medical University

    Chongqing, Chongqing Municipality, China

  • Guangzhou First People's Hospital

    Guangzhou, Guangdong, China

  • The Affiliated Hospital of Guiyang Medical College

    Guiyang, Guizhou, China

  • The First Affiliated Hospital of Zhengzhou Universtiy

    Zhengzhou, Henan, China

  • Wuhan Union Hospital

    Wuhan, Hubei, China

  • Tongji Hosp Tongji Med Col Huazhong Univ of Sci & Tech

    Wuhan, Hubei, China

  • Xiangya Hospital, Central South University

    Changsha, Hunan, China

  • The First Affliated Hospital of Soochow University

    Suzhou, Jiangsu, China

  • Affiliated Hospital of Jiangsu University

    Zhenjiang, Jiangsu, China

  • Pingxiang People's Hospital

    Pingxiang, Jiangxi, China

  • No.2 Hospital Affiliated to Jilin University

    Changchun, Jilin, China

  • Tianjin Huanhu Hospital

    Tianjin, Jinnan District, China

  • Jiangsu Province Hospital

    Nanjing, Nanjing, China

  • First Affiliated Hospital of Xi'an Jiaotong University

    Xi'an, Shaanxi, China

  • Jinan Central Hospital

    Jinan, Shandong, China

  • People's hospital of Rizhao

    Rizhao, Shandong, China

  • Shanghai East Hospital

    Shanghai, Shanghai Municipality, China

  • Zhongshan Hospital, Fudan University

    Shanghai, Shanghai Municipality, China

  • HuaShan Hospital Affiliated To Fudan University

    Shanghai, Shanghai Municipality, China

  • West China Hospital Sichuan University

    Chengdu, Sichuan, China

  • Tianjin Medical University General Hospital

    Tianjin, Tianjin Municipality, China

  • First Affiliated Hospital of Kunming Medical University

    Kunming, Yunnan, China

  • Zhejiang Hospital

    Hangzhou, Zhejiang, China

  • Bao Tou Central Hospital

    Baotou, Zizhiqu, China

  • Gobind Ballabh Pant Hospital

    New Delhi, India

  • Apollo Hospitals International Ltd.

    Ahmedabad, Gujarat, India

  • Artemis Hospital

    Gurgaon, Haryana, India

  • Mangala Hospitals & Mangala Kidney Foundation

    Mangalore, Karnataka, India

  • CHL - Apollo Hospital

    Indore, Madh Prad, India

  • Getwell Hospital & Research Institute

    Nagpur, Maharashtra, India

  • HCG Manavata Cancer Centre

    Nashik, Maharashtra, India

  • Deenanath Mangeshkar Hospital & Research Centre

    Pune, Maharashtra, India

  • All India Institute of Medical Sciences

    New Delhi, National Capital Territory of Delhi, India

  • Sir Ganga Ram Hospital

    New Delhi, National Capital Territory of Delhi, India

  • First Moscow State Medical University n.a. Sechenov

    Moscow, Russia

  • University Headache Clinic

    Moscow, Russia

  • OOO "Medis"

    Nizhny Novgorod, Russia

  • Academician I.P. Pavlov First St-Petersburg State Medical University

    Saint Petersburg, Russia

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.